| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.0048 | 1 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0031 | 1 |